Global High Content Screening Market 2017-2025 - Increasing Demand for Intensive Treatment Regimen for Chronic Disease - ResearchAndMarkets.com

DUBLIN--()--The "Global High Content Screening Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to ResearchAndMarkets.com's offering.

Global high content screening market was valued at US$ 1,199.0 Mn in 2016, and is expected to reach US$ 1,988.1 Mn by 2025 expanding at a CAGR of 5.82% from 2017 to 2025.

In 2016, North America held the largest revenue share mainly due to factors such as presence of pharmaceutical giants focusing on novel drug discovery and enhanced government spending in the research and development facilities in healthcare institutions.

Asia Pacific will be the fastest growing market throughout the forecast period 2017-2025, majorly due to factors such as competitive market due to presence of existing and budding biopharmaceuticals and medical imaging manufacturers and supportive regulatory environment for high content screening products.

Key Market Movements:

  • Increasing demand for intensive treatment regimen for chronic disease
  • Rising application of HCS technology in genome editing studies
  • Supportive regulatory environment for high content screening products
  • Public-private partnership between pharma giants and government agencies to expand R&D activities related to drug discovery and development

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. High Content Screening Market: Market Dynamics and Future Outlook

Chapter 4. Global High Content Screening Market, by Product, 2015 - 2025 (US$ Mn)

Chapter 5. Global High Content Screening Market, by Application, 2015 - 2025 (US$ Mn)

Chapter 6. Global High Content Screening Market, by Geography, 2015 - 2025 (US$ Mn)

Chapter 7. Company Profiles

  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck Millipore Corporation
  • Olympus Corporation
  • Perkin Elmer, Inc.
  • Tecan Group
  • Yokogawa Electric Corporation

For more information about this report visit https://www.researchandmarkets.com/research/bprv2v/global_high?w=4.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery